Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 ,inter alia, to consider and approve the Unaudited Limited Reviewed Financial Results (Standalone and Consolidated) of the Company for quarter II and half year ended on September 30, 2024, of Financial Year 2024-25.